Non-Small Cell Lung Cancer Market to Observe Utmost CAGR of 13.9% by 2030

Published August 14, 2023

Non-Small Cell Lung Cancer Market

Global Non-Small Cell Lung Cancer Market report can be broadened from market scenarios to comparative pricing between major players, cost and profit of the specified market regions. When every business is competing to win the race, market research report is one of the major factors that will help to succeed. The report provides explanation about market trends, future prospects, market restraints, leading market drivers, market segments, key developments, key players in the market, and competitor strategies. Global Non-Small Cell Lung Cancer Market research report is very consistent as all the data and information regarding the HEALTHCARE industry is derived via authentic sources such as websites, journals, annual reports of the companies, and magazines.

Under competitive analysis section of Global Non-Small Cell Lung Cancer Market report, major key players existing in the market are revealed along with different details such as company profiles, their market share analysis, and their diverse strategies which make them prosper in the market. This market report also provides notable data, present market trends, future events, market environment, technological innovation, forthcoming technologies and the technical advancement in the relevant industry. The finest Global Non-Small Cell Lung Cancer Market report is built by chewing over several fragments of the present and upcoming market scenario because an utter way to forecast what future holds is to comprehend the trend today.

According to data published by the Institute for Clinical and Economic Review (ICER) and the National Institutes of Health (NIH), approximately 85% of lung cancer cases in the United States are NSCLC. Squamous cell carcinoma accounted for 30% of the cases, adenocarcinoma accounted for 40%, and large-cell carcinoma accounted for 15%. Furthermore, all other country-based registries reported nearly the same percentage of NSCLC and its major subtypes.

Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @

Data Bridge Market Research analyses that the non-small cell lung cancer market which is USD 26948.36 million in 2022, is expected to reach USD 76334.72 million by 2030, at a CAGR of 13.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Overview:

Non-small cell lung carcinoma (NSCLC), also known as non-small cell lung cancer, is the most common type of lung cancer. The term “non-small cell” refers to the appearance of cancer cells under a microscope. Small cell lung cancer is named after the size of the cells (SCLC). According to the American Cancer Society, about 80 to 85 percentTrusted Source of all lung carcinomas fall into the non-small cell category. NSCLC is less likely to spread than SCLC and has a higher survival rate. The majority of people with early-stage NSCLC survive at least 5 years, but the survival rate is much lower if the cancer has spread to other tissues at the time of diagnosis.

Non-Small Cell Lung Cancer Market Scope and Segmentation  

Forecast Period 2023 to 2030
Base Year 2022
Historic Years 2021 (Customizable to 2015 – 2020)
Quantitative Units Revenue in USD Million, Volumes in Units, Pricing in USD


  • Lack of Skilled Professionals

Lack of trained professionals who are unaware of treatment methods for this disease may limit the growth of the global non-small cell lung cancer market during the forecast period.

This non-small cell lung cancer market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the non-small cell lung cancer market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Some of the major players operating in the non-small cell lung cancer market are:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • Novartis AG (Switzerland)
  • Bayer AG (Germany)
  • Lilly (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Aurobindo Pharma (India)
  • Lupin (India)
  • Johnson & Johnson Private Limited (U.S.)

To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@

Recent Developments

  • In 2019, Pfizer Inc., a multinational pharmaceutical and biotechnology corporation based in the United States, received European Commission (EC) marketing authorization for the LORVIQUA drug, a monotherapy drug used to treat anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).
  • In 2021, Daiichi Sankyo received FDA approval for adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal (GEJ) adenocarcinoma.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the this research report
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market
  • Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies

Top Key Topics Covered:

  1. Strategic Imperatives
  • Factors Creating Pressure on Growth
  • The Strategic Imperative
  • Growth Opportunities Fuel the Growth Pipeline Engine
  • Research Methodology
  1. Scope and Segmentation
  • Research Context and Scope of Analysis
  • Segmentation
  • Other Techniques for This Research Report Management
  1. Growth Opportunity Analysis
  • Growth Drivers
  • Growth Restraints
  1. Introduction
  • The Impact of the COVID-19 Pandemic and Post
  • Future Growth
  1. Innovation Ecosystem


Non-Small Cell Lung Cancer Market Scope

Cancer Type

  • Non-Small Cell Lung Cancer
  • Metastatic Lung Cancer
  • Pulmonary Neuroendocrine Tumours
  • Mediastina Tumours
  • Mesothelioma
  • Chest Wall Tumours


  • Adenocarcinomas
  • Squamous Cell Carcinoma
  • Large Cell Carcinomas
  • Others

Molecule Type

  • Small Molecules
  • Biologics

Drug Class

  • Alkylating Agents
  • Antimetabolites
  • EGFR Inhibitors
  • Mitotic Inhibitors
  • Multi-kinase Inhibitors
  • Others

 Treatment Type

  • Chemotherapy
  • Radiation Therapy
  • Targeted Therapy
  • Immunotherapy
  • Others


  • CT Scan
  • X-Rays
  • Sputum Cytology
  • Bronchoscopy
  • Laboratory Tests
  • Thoracoscopy
  • Others

 Therapy Type

  • Single Drug Therapy
  • Combination Therapy

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

 Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online
  • Others

Browse Detailed Summary of Research Report with TOC:

Some of the Most Important Questions Scrutinized in the Business Intelligence Report:

  • What are the key growth parameters for this global market during the forecast period?
  • Which key players are expected to hold the largest market share over the forecast period?
  • Who are the leading vendors and manufacturers in this market?
  • What are the key strategies adopted by leading players in the market for business development and geographical expansion?
  • Which end-use industries can trigger high demand in the market over the forecast period?
  • What are the key segments in this market?
  • Which regional player will have anticipated leading the global market in terms of size?
  • What is the impact of the novel coronavirus pandemic?
  • Which obstacles must new players overcome in order to occupy a major position?

Top DBMR Healthcare Reports:

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475


CDN Newswire